Nuvectis Pharma, Inc.

NVCT·NasdaqCM·Healthcare
Compare
18.47−0.87 (−4.50%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close19.34
Open19.08
Day range17.1020.55
52-week range5.5529.28
Off day high−10.12%
Off 52-week high−36.91%
Volume373.43K
Avg. volume (3M)192.66K
Market cap602.94M
EPS (TTM)-2.00
Forward P/E-19.24
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.21
Shares outstanding32.64M
Short interest11.06% of float
Earnings dateNov 4, 2026
Analyst target35.40
Profit margin0.00%

Against its peers

Compare in full ›
NVCT NUVB AKTS NVAX NKTR CBIO
Market cap 602.94M 1.66B 845.42M 1.76B 1.31B 513.37M
P/E (TTM) — — — — — —
Forward P/E -19.2 -315.3 -7.1 -65.0 -3.7 -5.3
Price/book 5.1 5.4 1.7 -9.2 1.5 2.9
Dividend yield — — — — — —
1-year change +242.30% −4.67% −33.30% +25.88% −30.41% +5.07%
Today −4.50% +0.85% +1.74% +10.02% +1.91% +5.82%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Nuvectis Pharma's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Nuvation Bio Inc.NUVB · Biotechnology 1.66B 4.7300 +0.85%
Aktis Oncology, Inc.AKTS · Biotechnology 845.42M 15.20 +1.74%
Novavax, Inc.NVAX · Biotechnology 1.76B 10.65 +10.02%
Nektar TherapeuticsNKTR · Biotechnology 1.31B 38.48 +1.91%
Crescent Biopharma, Inc.CBIO · Biotechnology 513.37M 13.82 +5.82%
vTv Therapeutics Inc.VTVT · Biotechnology 95.01M 24.03 +2.04%
Atea Pharmaceuticals, Inc.AVIR · Biotechnology 357.71M 4.4600 +6.95%
NovaBridge BiosciencesNBP · Biotechnology 117.16M 1.0100 0.00%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Arbutus Biopharma CorporationABUS · Warminster, PA 622.30M 4.0600 +4.64%
Bicara Therapeutics Inc.BCAX · Boston, MA 588.28M 8.89 −0.78%
Geron CorporationGERN · Foster City, CA 693.87M 1.0800 +16.13%
Zevra Therapeutics, Inc.ZVRA · Boston, MA 663.32M 11.17 +8.87%
Aclaris Therapeutics, Inc.ACRS · Wayne, PA 570.34M 3.6800 −1.60%
Iambic Therapeutics, Inc.IAM · San Diego, CA 635.17M 13.40 −0.67%
Adlai Nortye Group Ltd.ANL · Singapore, Singapore 618.86M 9.61 +0.31%
Apnimed, Inc.APMD · Cambridge, MA 636.95M 15.30 +1.59%

Also based in Fort Lee, New Jersey, then elsewhere in New Jersey.

Company Mkt cap Price Today
Pioneer Power Solutions, Inc.PPSI · Fort Lee, NJ 26.64M 2.4000 −2.44%
Johnson & JohnsonJNJ · New Brunswick, NJ 665.19B 276.32 +3.81%
Merck & Co., Inc.MRK · Rahway, NJ 370.96B 150.36 +3.93%
Bristol-Myers Squibb CompanyBMY · Princeton, NJ 131.21B 64.19 +4.02%
JOHNSON & JOHNSON CDR (CAD HEDGJNJ.NE · New Brunswick, NJ 915.54B 35.27 +4.32%
Automatic Data Processing, Inc.ADP · Roseland, NJ 119.83B 303.54 +2.54%
PBF Energy Inc.PBF · Parsippany, NJ 8.61B 72.62 −6.67%
Access Bio, Inc.950130.KQ · Somerset, NJ 64.19B 1,825.00 −3.95%

The stocks whose daily moves over the past year went most closely with Nuvectis Pharma's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Immix Biopharma, Inc.IMMX · Correlation 0.32 660.74M 7.97 +3.37%

What visitors to Nuvectis Pharma's page also look at.

Company Mkt cap Price Today
Immix Biopharma, Inc.IMMX 660.74M 7.97 +3.37%
NeuroSense Therapeutics Ltd.NRSN 2.69M 1.4200 +9.23%
Anghami Inc.ANGH 32.18M 3.5500 +1.72%
Entrada Therapeutics, Inc.TRDA 197.02M 5.06 +7.20%
Foghorn Therapeutics Inc.FHTX 124.71M 2.1000 −1.41%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All NVCT news ›
markets.businessinsider.com·Positive

Nuvectis Pharma announces NXP200 granted BTD in China

Nuvectis Pharma (NVCT) announced that NXP200 has been granted Breakthrough Therapy Designation, BTD, for the treatment of patients with BRAF V60... Nuvectis Pharma announces NXP200 granted BTD in China Nuvectis Pharma (NVCT) announced that…

NVCTJHPCYNVSAZN
The Globe and Mail·Negative

Nuvectis Pharma Launches New $200 Million ATM Program

Nuvectis Pharma ( (NVCT) ) has shared an announcement. The most recent analyst rating on (NVCT) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Nuvectis Pharma stock, see the NVCT Stock Forecast…

NVCTMSFTNVSQCOM
markets.businessinsider.com·Positive

Nuvectis Pharma files $200M mixed securities shelf

16:39 EDT Nuvectis Pharma (NVCT) files $200M mixed securities shelfSummer Sale - Claim 70% Off TipRanks Unlock powerful investing tools with Tip... Nuvectis Pharma files $200M mixed securities shelf 16:39 EDT Nuvectis Pharma (NVCT) files…

NVCTNVVE

From the 4Search news index, newest first.

In the news

21mentions in 30 days
21with it in the headline
Positivesentiment

Mentioned with

Novo Nordisk14Novartis10Nuvectis Pharma, Inc10Astrazeneca7Barclays7Citigroup7Eli Lilly7Nuo Therapeutics, Inc.7

People in the coverage

Danessa Lincoln12Sarita Garza11Baker Hughes7Mitch Edgeman7Cantor Fitzgerald6Claude5

Themes

Healthcare16SEC Filings9Pharmaceuticals8Finanzen7Pharma7Biotech6Nvo5Equities4

Most coverage from

  1. theglobeandmail.com12
  2. markets.businessinsider.com5
  3. globenewswire.com1
  4. manilatimes.net1
  5. stocktitan.net1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance